A Phase I Study of Hyperthermic Isolated Hepatic Perfusion with Oxaliplatin in the Treatment of Unresectable Liver Metastases from Colorectal Cancer
- 25 November 2008
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 16 (2) , 385-394
- https://doi.org/10.1245/s10434-008-0179-5
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Factors that influence treatment strategies in advanced colorectal cancerEuropean Journal of Surgical Oncology, 2007
- Extending the frontiers of resectability in advanced colorectal cancerEuropean Journal of Surgical Oncology, 2007
- Bringing unresectable liver disease to resection with curative intentEuropean Journal of Surgical Oncology, 2007
- Improving Resectability of Hepatic Colorectal Metastases: Expert Consensus StatementAnnals of Surgical Oncology, 2006
- Epidemiology and Management of Liver Metastases From Colorectal CancerAnnals of Surgery, 2006
- Liver Resection for Multiple Colorectal MetastasesArchives of Surgery, 2002
- Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal MetastasesAnnals of Surgery, 2002
- Management of hepatic metastasesLiver Transplantation and Surgery, 1999
- Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant ChemotherapyAnnals of Surgery, 1996
- Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancerBritish Journal of Surgery, 1995